Legend Biotech shares first in vivo CAR-T data, its next act after Carvykti

Ying Huang, Legend Biotech CEO June 2, 2026 09:31 AM EDTUpdated 09:54 AM R&DCell/Gene Tx Leg­end Biotech shares first in vi­vo CAR-T da­ta, its next act af­ter Carvyk­ti Lei Lei Wu News Reporter Leg­end Biotech’s long-await­ed first show­ing of in vi­vo CAR-T da­ta is here, fu­el­ing mo­men­tum in the grow­ing field. Leg­end re­port­ed re­sults Tues­day on 12 lym­phoma … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER